The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Adaptimmune Therapeutics Plc ADR’s current trading price is -38.05% away from its 52-week high, while its distance from the 52-week low is 202.38%. The stock’s price range for this period has been between $0.42 and $2.05 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.48 million for the day, a number notably lower than the average daily volume of 1.89 million over the last three months.
Adaptimmune Therapeutics Plc ADR’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $2.05 on 03/08/24 and a low of $0.42 for the same time frame on 11/28/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Adaptimmune Therapeutics Plc ADR (ADAP) has experienced a quarterly rise of 38.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 288.51M and boasts a workforce of 449 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0065, with a change in price of +0.7758. Similarly, Adaptimmune Therapeutics Plc ADR recorded 1,464,560 in trading volume during the last 100 days, posting a change of +156.98%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ADAP stands at 0.64. Similarly, the long-term debt-to-equity ratio is also 0.50.
ADAP Stock Stochastic Average
Adaptimmune Therapeutics Plc ADR’s raw stochastic average for the past 50 days is presently 39.45%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 6.52%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 18.74% and 19.22%, respectively.
ADAP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 60.15%. However, over the past six months, we’ve seen a weaker performance of 85.13%. The price of ADAP leaped by -17.53% over the last 30 days. And in the last five days, it has fallen by -7.97%.
